Equity Overview
Price & Market Data
Price: $0.73
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $56,658,804
Volume: 0
Performance Metrics
1 Week: -42.30%
1 Month: -31.10%
3 Months: 33.56%
6 Months: 121.0%
1 Year: 43.38%
YTD: 33.56%
Details
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It is developing respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.